Panacea Biotec Limited, one of India's leading biotechnology company, has announced the launch of its new range of high-quality pediatric food & nutritional products ChilRun, ChilRun Full, ChilRun No Sucrose, ChilRun 7+ in different flavours and sizes in India by its wholly owned subsidiary, Panacea Biotec Pharma Limited ("PBPL").
Shares of Panacea Biotec Limited was last trading in BSE at Rs. 133.50 as compared to the previous close of Rs. 137.50. The total number of shares traded during the day was 5917 in over 313 trades.
The stock hit an intraday high of Rs. 138.05 and intraday low of 132.60. The net turnover during the day was Rs. 799828.00.